Summary
Overview
Work History
Education
Skills
Websites
Accomplishments
Timeline
Generic
Jason Slye

Jason Slye

Andover

Summary

High performer and experienced leader in Quality and Operations with a demonstrated history of working in the biotechnology industry. Strong professional skilled in Good Laboratory, Good Manufacturing, Good Clinical Practices and Good Pharmacovigilance Practice (GLP, GMP, GCP, GVP) and Continuous Improvement. Technically competent Quality leader that has provided guidance and expertise in all Quality functional areas to product CMC teams in order to develop the overall product Quality strategy for a range of product modalities such as biologics, gene therapy, microbiome and plasma. Quality leader as the main Quality representative on several laboratory/facility design and build projects worldwide. Demonstrated track record of implementing cost savings initiatives, Quality KPIs/metrics and Quality improvement programs.

Overview

23
23
years of professional experience

Work History

Associate Vice President, Quality Control

Lyra Therapeutics
10.2023 - Current
  • Responsible for implementation of a new QC lab in Waltham
  • Established QC strategy including the organizational structure and hiring plan
  • Coach and develop a staff of 5 Directors/Analysts
  • Manage routine testing of raw materials, in-process, drug substance, final product and stability study samples for clinical phase combination drug/device products at both internal and external QC labs
  • Oversight of Environmental Monitoring, sample management and stability management
  • Ensure that QC procedures, practices and analytical methods are in compliance with the applicable compendial, regulatory and customer requirements
  • Coordinate with Analytical Development on the method transfers from the CTLs to the new QC lab
  • Responsible for records associated with Quality Control testing including but not limited to leading and managing QC investigations OOT/OOS), change controls, CAPAs, and ensure investigations are thoroughly conducted
  • Responsible for writing and reviewing the Module 3 sections for INDs related to stability, product testing

Executive Director, Quality Control

Seres Therapeutics
06.2022 - 10.2023

*Also held the role of Executive Director, Product Quality

  • Managed routine testing of in-process, raw materials, drug substance, final product and stability study samples for clinical and commercial phase microbiome products
  • Coached and developed a staff of 30 Director to Analyst level staff and contractors
  • Established a QC center of excellence to perform release and stability testing for first oral microbiome commercial product
  • Ensured that QC procedures, practices and analytical methods are in compliance with the applicable compendial, regulatory and customer requirements
  • Led the Analytical Sciences & Technology function responsible for test method introduction/qualification/validation and instrument qualification/validation both internally and externally
  • Led the Stability function responsible for performing statistical analysis of QC data including assay trending, generation of stability protocols and reports and execution of stability scheduling/pulls
  • Led the Product Quality Management (PQM) function responsible for the holistic view of product quality from Toxicology throughout the clinical phases and into commercial lifecycle maintenance
  • Led the Technical Services function responsible for sample management, contamination control, LIMS implementation, and system administration of non-networked laboratory systems
  • Chaired the specification review committee (SRC)
  • Authored and reviewed the Module 3 sections for INDs and BLA related to stability, product testing and manufacturing

Senior Director, Global Quality Control

Beam Therapeutics
10.2020 - 06.2022

*Also held the role of Director, Product Quality & External QC

  • Established the initial Quality Control function (QC center of excellence) including setting the QC strategy and hiring plan
  • Coached and developed a staff of 5 Associate Director to Analyst level staff and contractors
  • Established global standards related to raw material oversight, test method introduction/qualification/validation and stability for clinical cell and gene therapy products
  • Transitioned to lead the Global Quality Control function responsible for stability, external testing laboratory oversight and method qualifications after NC site was established
  • Led the Product Quality Management (PQM) function responsible for the holistic view of product quality from Toxicology throughout the clinical phases and into commercial lifecycle maintenance
  • Led the GLP and GVP compliance encompassing research and pharmacovigliance activities
  • Authored and reviewed the Module 3 sections for INDs related to stability, product testing and manufacturing.

Director, Affiliate Quality

Biogen
09.2019 - 10.2020
  • Partnered with the 29 Biogen affiliate offices to manage quality issues and process improvement opportunities to ensure Product Quality and clinical trial adherence
  • Coached and developed a staff of 8 Managers/Specialists and contractors based in the US and Europe
  • Managed Global Safety and Regulatory Sciences (GSRS) compliance and CAPA activities including KPI/KQI/metric development and trending to ensure Product Quality and clinical trial adherence
  • Managed Quality oversight of Pharmacovigilance Safety Master File (PSMF), Global Case Management, Safety Data Exchange/Pharmacovigilance Agreements (SDEA/PVAs) and Individual Case Safety Reports (ICSR)

Director, Global Quality

Takeda/Shire
12.2011 - 09.2019

*Also held the following roles through internal promotions:

Associate Director, QC

Manager, QC

Sr Quality Project Manager

  • Managed the internal and external business network strategy for the Quality Laboratories across Shire
  • Managed the core Quality business processes and business optimization on a network wide level (13 internal labs, 32 external labs/CMOs) that ranged from various modalities including biologics, gene therapy and plasma
  • Coached and developed a staff of 30 Associate Director to Specialist level staff and contractors based in the US and Europe
  • Implemented new analytical testing technology: Reduced Identity testing TAT from 3 days to 2 hours and reduced testing costs by $250k annually
  • Served as the consolidated capital holder for all of Quality, ranging from $10M to $50M
  • Developed network-based strategy for a holistic and efficient method for QC testing (who, where & what) both internally and externally
  • Managed raw material testing and release as well as raw material inspection and sampling for GMP warehouse operations (components/intermediates)
  • Quality Lead on design/ build for facility startup activities related to labs and warehousing including infrastructure changes for labs and facility renovations (California, Massachusetts, Ireland, Austria, Argentina)
  • Quality Operational Efficiency (OE) point of contact to implement key OE principles and initiatives across Quality, including KPI/metrics harmonization, trending and optimization across the network, Lean Labs, Lab Supplies Stockroom implementation and implementation of vendor managed inventory (VMI)

Senior Supervisor, Quality Control

Pfizer/Wyeth/Genetics Institute
08.2001 - 12.2011

*Also held the following roles through internal promotions:

Supervisor II, QC

Supervisor I, QC

Scientist II, QC

Scientist I, QC

  • Managed the Quality Control Laboratory Systems group in support of LabWare LIMS system support and implementation
  • Managed the Operational Efficiency (OE) group to lead the implementation of Lean Laboratory principles/design
  • Coached and developed a staff of 10 specialists
  • Managed and trended the department KPIs/metrics and headcount and applied OE principles to workflow
  • Initiated projects targeted at cost savings and enhanced compliance within Quality Control
  • Created ways to enhance laboratory processes in order to move to a completely paper less system
  • Performed routine Quality Control testing of in-process, bulk Drug Substance, final Drug Product and stability of clinical and commercial phase vaccines and biologics
  • Performed method transfer to and from external companies (GSK, Genentech)

Education

Masters of Business Administration (MBA) - Supply Chain Management

Northeastern University
Boston, MA
12.2019

Masters of Science (MS) - Regulatory Affairs

Northeastern University
Boston, MA
05.2008

Bachelors of Science (BS) - Health Science

Merrimack College
North Andover, MA
05.2001

Skills

  • Quality regulations (ICH, 21CFR, Eudralex, GMP, GLP, GVP, GCP, USP, Ph Eur, JP)
  • Laboratory/Facility design and build
  • Development of individuals/teams
  • Worked on multiple modalities (cell/gene therapy, biologics, vaccines, microbiome, combo drug/device)
  • Certified Quality Auditor (ASQ)
  • Statistical tools (MiniTab, JMP)
  • Lean Six Sigma Green Belt (ASQ)
  • Windows Office (Word, Excel, Powerpoint, Visio, Project)

Accomplishments

    Shire Quality Vision award – Recipient of the Shire Quality Vision award for major improvements to the raw material non-conforming material process to improve overall Product Quality. Improved closure time, compliance and supplier oversight as part of the improvements


    Implemented new analytical testing technology:

  • Reduced Identity testing TAT from 3 days to 2 hours
  • Reduction in testing costs of $250k annually

Timeline

Associate Vice President, Quality Control

Lyra Therapeutics
10.2023 - Current

Executive Director, Quality Control

Seres Therapeutics
06.2022 - 10.2023

Senior Director, Global Quality Control

Beam Therapeutics
10.2020 - 06.2022

Director, Affiliate Quality

Biogen
09.2019 - 10.2020

Director, Global Quality

Takeda/Shire
12.2011 - 09.2019

Senior Supervisor, Quality Control

Pfizer/Wyeth/Genetics Institute
08.2001 - 12.2011

Masters of Business Administration (MBA) - Supply Chain Management

Northeastern University

Masters of Science (MS) - Regulatory Affairs

Northeastern University

Bachelors of Science (BS) - Health Science

Merrimack College
Jason Slye